Compare SMTI & MMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SMTI | MMD |
|---|---|---|
| Founded | 1982 | 2012 |
| Country | United States | United States |
| Employees | 108 | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 313.5M | 280.2M |
| IPO Year | 2008 | N/A |
| Metric | SMTI | MMD |
|---|---|---|
| Price | $34.11 | $15.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $34.00 | N/A |
| AVG Volume (30 Days) | ★ 293.1K | 44.6K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.88% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $15,586,976.00 | N/A |
| Revenue This Year | $17.31 | N/A |
| Revenue Next Year | $12.48 | N/A |
| P/E Ratio | $681.80 | ★ N/A |
| Revenue Growth | ★ 32.47 | N/A |
| 52 Week Low | $16.05 | $14.40 |
| 52 Week High | $35.70 | $15.82 |
| Indicator | SMTI | MMD |
|---|---|---|
| Relative Strength Index (RSI) | 82.74 | 33.72 |
| Support Level | $20.47 | $14.91 |
| Resistance Level | N/A | $15.43 |
| Average True Range (ATR) | 0.94 | 0.14 |
| MACD | 0.73 | -0.02 |
| Stochastic Oscillator | 97.49 | 18.00 |
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
NYLI MacKay DefinedTerm Muni Opportunities Fund is a USA-based diversified closed-end management investment company. The fund's investment objective is to seek current income exempt from regular U.S. Federal income taxes as well as total return. The company predominantly invests in municipal bonds, the interest on which is, in the opinion of bond counsel to the issuers, generally excludable from gross income for regular U.S. Federal income tax purposes.